Metraipolis › archive › dc_b50ca35110e0
Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma — Europe PMC PMID:41375019
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41375019
- DOI
- 10.3390/cancers17233818
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:44:02.888Z
- SHA-256 of the archived text
67247e2e1d1967359ba6143ed4e77db59911dac9f579f1b769d3fbd859b4d456- Stable URL of this page
https://metraipolis.com/documento/dc_b50ca35110e0
How to cite
Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma — Europe PMC PMID:41375019 — Europe PMC (en), https://europepmc.org/article/MED/41375019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b50ca35110e0 (Metraipolis archive dc_b50ca35110e0, sha256 67247e2e1d1967359ba6143ed4e77db59911dac9f579f1b769d3fbd859b4d456)
BibTeX
@misc{dcb50ca35110e0,
title = {Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma — Europe PMC PMID:41375019},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41375019},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b50ca35110e0; sha256 67247e2e1d1967359ba6143ed4e77db59911dac9f579f1b769d3fbd859b4d456},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375019. Agents can read the archived copy with the MCP tool read_document.